glp 1 agonists for alcohol use disorder Repurposing GLP-1 receptor disorder: a systematic review and meta-analysis | Diabetology & Metabolic Syndrome GLP-1 Agonists for Alcohol Use

Although traditionally considered to have limited efficacy in patients with diabetes, recent studies indicate that, when acting synergistically with GLP-1, GIP enhances insulinotropic effects and improves overall metabolic homeostasis (20, 21)

Possible Side Effects of Wegovy ( ozempic ) Most Common Side Effects: Nausea Vomiting Diarrhea Stomach pain Constipation If side effects persist or worsen, contact your healthcare provider

M., Martinou, E

doi:10.1186/s13063-019-3259-x 202

doi: 10.1016/j.coph.2016.08.005 [DOI] [PubMed] [Google Scholar] 110

108 Dulaglutide Dulaglutide was approved by the FDA in 2014 for the treatment of T2DM